These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2015430)

  • 41. Psychotic symptoms as a continuum between normality and pathology.
    Stip E; Letourneau G
    Can J Psychiatry; 2009 Mar; 54(3):140-51. PubMed ID: 19321018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of positive symptoms on social cognition in first-episode schizophrenia is modified by the presence of negative symptoms.
    Bliksted V; Videbech P; Fagerlund B; Frith C
    Neuropsychology; 2017 Feb; 31(2):209-219. PubMed ID: 27808537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The psychometric properties of the Vineland Adaptive Behavior Scales in children and adolescents with mental retardation.
    de Bildt A; Kraijer D; Sytema S; Minderaa R
    J Autism Dev Disord; 2005 Feb; 35(1):53-62. PubMed ID: 15796122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical characteristics of late-onset schizophrenia and delusional disorder.
    Yassa R; Suranyi-Cadotte B
    Schizophr Bull; 1993; 19(4):701-7. PubMed ID: 8303221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evolution of schizophrenia: role of symptomatology in the reliability of 11 diagnostic systems for schizophrenia].
    Dollfus S; Petit M; Menard JF; Lesieur P
    Ann Med Psychol (Paris); 1993 Apr; 151(4):322-5. PubMed ID: 8285501
    [No Abstract]   [Full Text] [Related]  

  • 46. Factor analysis of Wechsler Adult Intelligence Scale-Revised in developmentally disabled persons.
    Di Nuovo SF; Buono S
    Psychol Rep; 2006 Dec; 99(3):953-9. PubMed ID: 17305220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Polydiagnostic approach to schizophrenia. Validation of a computerized checklist (Diagnostic and Prognostic Scales)].
    Dollfus S; Petit M; Ménard JF; Brazo P; Assouly-Besse F; Preterre P; Lesieur P
    Encephale; 1994; 20(2):91-101. PubMed ID: 8050383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. On the descriptive validity of DSM III schizophrenia.
    Fabrega H; Ahn C; Mezzich JE
    Psychopathology; 1992; 25(2):79-89. PubMed ID: 1502295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No, it is not possible to be schizophrenic yet neuropsychologically normal.
    Wilk CM; Gold JM; McMahon RP; Humber K; Iannone VN; Buchanan RW
    Neuropsychology; 2005 Nov; 19(6):778-86. PubMed ID: 16351353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hallucinations in Kenyan schizophrenic patients.
    Ndetei DM; Singh A
    Acta Psychiatr Scand; 1983 Mar; 67(3):144-7. PubMed ID: 6858710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Source memory errors in schizophrenia, hallucinations and negative symptoms: a synthesis of research findings.
    Brébion G; Ohlsen RI; Bressan RA; David AS
    Psychol Med; 2012 Dec; 42(12):2543-54. PubMed ID: 22716666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the Shipley Institute of Living Scale and WAIS-R IO scores for a sample of public sector psychiatric inpatients.
    Hays JR; Emmons J; Wagner A; Stallings G
    Psychol Rep; 1997 Jun; 80(3 Pt 1):920-2. PubMed ID: 9198393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of assessment methods for depression in mental retardation.
    Rojahn J; Warren VJ; Ohringer S
    J Autism Dev Disord; 1994 Jun; 24(3):305-13. PubMed ID: 8050984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hallucinatory disorder: preliminary data for a clinical diagnostic proposal.
    Mauri MC; Valli I; Ferrari VM; Regispani F; Cerveri G; Invernizzi G
    Cogn Neuropsychiatry; 2006 Sep; 11(5):480-92. PubMed ID: 17354083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Childhood abuse and the positive symptoms of schizophrenia.
    Ross CA; Anderson G; Clark P
    Hosp Community Psychiatry; 1994 May; 45(5):489-91. PubMed ID: 8045548
    [No Abstract]   [Full Text] [Related]  

  • 56. Predictive validity of the K-SADS-PL 2009 version in school-aged and adolescent outpatients.
    Jarbin H; Andersson M; Råstam M; Ivarsson T
    Nord J Psychiatry; 2017 May; 71(4):270-276. PubMed ID: 28413935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical correlates of self-mutilation among psychiatric inpatients.
    Langbehn DR; Pfohl B
    Ann Clin Psychiatry; 1993 Mar; 5(1):45-51. PubMed ID: 8348198
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A study of thought disorder in paranoid and non-paranoid schizophrenia.
    Mazumdar PK; Chaturvedi SK; Gopinath PS
    Psychopathology; 1991; 24(3):166-9. PubMed ID: 1754647
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tardive dyskinesia and positive and negative symptoms of schizophrenia. A study using instrumental measures.
    Yuen O; Caligiuri MP; Williams R; Dickson RA
    Br J Psychiatry; 1996 Jun; 168(6):702-8. PubMed ID: 8773812
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Negative symptoms: relationship to other schizophrenic symptom classes.
    McKenna PJ; Lund CE; Mortimer AM
    Br J Psychiatry Suppl; 1989 Nov; (7):104-7. PubMed ID: 2619978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.